Top Stories
This week on Talking Headways we’re joined by Mike Eliason of larch…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
October 14, 2024: SpaceX’s Falcon Heavy is seen from the roof…
US stocks struggled to make headway on Thursday as investors digested…
The government has announced the formation of the 8th Pay Commission…
Image source: Getty Images Over the past year or so I’ve…
Investments
Adobe Inc. outlines executive compensation changes Source link
Economy Insights
National News
BROOMFIELD, CO – January 24, 2025 (NEWMEDIAWIRE) – Aclarion, Inc., (Aclarion or the Company) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary…
HAMBURG, Germany, Jan. 24, 2025 (GLOBE NEWSWIRE) — In a release issued on January 21, 2025 by XCHG Limited (NASDAQ: XCHG), please note that an incorrect version…
David Owens, the Chief Medical (TASE:) Officer of Nexalin Technology , Inc. (NASDAQ:), has reported the purchase of common stock valued at a total of $7,700. The…
By Andrew Chung (Reuters) – President Donald Trump’s administration asked the U.S. Supreme Court on Friday to put on hold planned arguments in a bid by fuel…
By Ted Hesson and Hannah Lang WASHINGTON (Reuters) -The Trump administration is powering ahead with efforts to ramp up immigration enforcement, opening up the possibility of targeting…
Lucara Diamond ( (TSE:LUC) ) has shared an update. Lucara Diamond Corp. has received conditional approval to transition its Swedish stock listing from Nasdaq Stockholm to Nasdaq…